👉 incl. TILs, TCR-T & CAR-T + associated tx e.g. IL-2 & NMA-LD.
🔗 www.esmoiotech.org/article/S259...
@sophiawongyn.bsky.social
@fbmh-uom.bsky.social
👉 incl. TILs, TCR-T & CAR-T + associated tx e.g. IL-2 & NMA-LD.
🔗 www.esmoiotech.org/article/S259...
@sophiawongyn.bsky.social
@fbmh-uom.bsky.social
www.esmoiotech.org #ESMO
www.esmoiotech.org #ESMO
If you are presenting your work at #ESMOImmuno24, and potentially looking for a home for your research work, please consider submitting to our ESMO IOTECH journal:
🔗 esmoiotech.org
If you are presenting your work at #ESMOImmuno24, and potentially looking for a home for your research work, please consider submitting to our ESMO IOTECH journal:
🔗 esmoiotech.org
🎯 EiC: @haanenjohn.bsky.social
Section Editors:
@michalbassani.bsky.social (NeoAg/TILs)
@danielathommen.bsky.social (Biomarkers/novel IO targets)...
If you are presenting your work at #ESMOImmuno24, and potentially looking for a home for your research work, please consider submitting to our ESMO IOTECH journal:
🔗 esmoiotech.org
🎯 EiC: @haanenjohn.bsky.social
Section Editors:
@michalbassani.bsky.social (NeoAg/TILs)
@danielathommen.bsky.social (Biomarkers/novel IO targets)...
🔹 Hope S. Rugo as Editor-in-Chief of ESMO Open
🔹 John Haanen & Sherene Loi as Co-Editors-in-Chief of ESMO IOTECH
🔗 Learn more: https://ow.ly/HtXg50XlOrQ
@hoperugo.bsky.social
🔹 Hope S. Rugo as Editor-in-Chief of ESMO Open
🔹 John Haanen & Sherene Loi as Co-Editors-in-Chief of ESMO IOTECH
🔗 Learn more: https://ow.ly/HtXg50XlOrQ
@hoperugo.bsky.social
Also check out @DrGopalIyer recent review on GD on #ESMO #IOTech
A GD Type of Cancel Culture - www.esmoiotech.org/article/S259...
#CellTherapy
#GammaDelta
#NKT
Also check out @DrGopalIyer recent review on GD on #ESMO #IOTech
A GD Type of Cancel Culture - www.esmoiotech.org/article/S259...
#CellTherapy
#GammaDelta
#NKT
newslinker.co/iotech-colla...
newslinker.co/iotech-colla...
https://bit.ly/4oV3iUI
https://bit.ly/4oV3iUI
@drbetofmdphd.bsky.social
@dgfeller.bsky.social
@kevlitchfield.bsky.social
@artkrieg.bsky.social
@bertrandrouty.bsky.social
@charlesswanton.bsky.social
@pamsharmamdphd.bsky.social
🦋 Follow for insights into #CancerImmunology!
@drbetofmdphd.bsky.social
@dgfeller.bsky.social
@kevlitchfield.bsky.social
@artkrieg.bsky.social
@bertrandrouty.bsky.social
@charlesswanton.bsky.social
@pamsharmamdphd.bsky.social
🦋 Follow for insights into #CancerImmunology!